Royalty Pharma PLC (RPRX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Pablo Legorreta
Employees:
5
110 EAST 59TH STREET, NEW YORK, NY 10022
(212) 883-0200

Royalty Pharma AG is a privately owned company which invests in royalty interests in pharmaceutical and biopharmaceutical products. The Company provides liquidity to royalty owners, and assumes the future risks and rewards of ownership.

Data derived from most recent annual or quarterly report
Market Cap 16.013 Billion Shares Outstanding427.006 Million Avg 30-day Volume 1.252 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 52.59 / 34.25 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

Are you looking for this stock instead?

View SEC Filings from RPRX instead.

View recent insider trading info

Funds Holding RPRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RPRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

128.4 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FERNANDEZ HENRY A

  • Director
42,678 2021-09-30 6

BASSLER BONNIE L

  • Director
22,772 2021-09-30 5

RIGGS RORY B

  • Director
7,286,709 2021-09-28 4

REDDOCH JAMES F. EVP, RESEARCH & INVESTMENTS

  • Officer
1,195,830 2021-07-26 12

LLOYD GEORGE W. EVP, INVESTMENTS & GC

  • Officer
1,896,820 2021-07-26 12

FORD WILLIAM E

  • Director
2,046,365 2021-06-30 2

LOVE TED W

  • Director
22,866 2021-06-25 1

DESOUZA ERROL B

  • Director
50,370 2021-06-25 1

NORDEN GREGORY

  • Director
50,370 2021-06-25 1

ENGELBERT CATHERINE M.

  • Director
19,136 2021-06-25 1

URIST MARSHALL EVP & CO-HEAD OF R&I

  • Officer
19,020 2021-06-04 5

LEGORRETA PABLO G. CEO, CHAIRMAN OF THE BOARD

  • Officer
  • Director
8,436,827 2021-05-07 1

COYNE TERRANCE P. EVP & CFO

  • Officer
1,346,858 2021-05-07 4

HITE CHRISTOPHER EVP & VICE CHAIRMAN

  • Officer
30,541 2021-03-23 1

ADAGE CAPITAL PARTNERS GP, L.L.C.

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
No longer subject to file 2020-12-17 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BASSLER BONNIE L - Director

2021-09-30 15:12:14 -0400 2021-09-30 A 992 $37.80 a 22,772 direct 0.249 -1.7432 0.249 2 -2.684 3

FERNANDEZ HENRY A - Director

2021-09-30 15:17:13 -0400 2021-09-30 A 992 $37.80 a 16,978 direct 0.249 -1.7432 0.249 2 -2.684 3

RIGGS RORY B - Director by new ventures iii llc

2021-09-30 15:56:58 -0400 2021-09-29 S 7,000 $36.67 d 2,074,540 indirect -2.9258 -2.0425 0.0 1 -2.9258 2

RIGGS RORY B - Director by new ventures select

2021-09-30 15:56:58 -0400 2021-09-29 J 109,814 d 789,492 indirect -2.9258 -2.0425 0.0 1 -2.9258 2

RIGGS RORY B - Director

2021-09-30 15:56:58 -0400 2021-09-29 J 5,299 a 622,745 direct -2.9258 -2.0425 0.0 1 -2.9258 2

RIGGS RORY B - Director by new ventures i llc

2021-09-30 15:56:58 -0400 2021-09-29 J 511,727 d 2,917,358 indirect -2.9258 -2.0425 0.0 1 -2.9258 2

RIGGS RORY B - Director by new ventures select

2021-09-30 15:56:58 -0400 2021-09-29 S 34,604 $36.31 d 899,306 indirect -2.9258 -2.0425 0.0 1 -2.9258 2

RIGGS RORY B - Director

2021-09-30 15:56:58 -0400 2021-09-29 J 2,334 a 617,446 direct -2.9258 -2.0425 0.0 1 -2.9258 2

RIGGS RORY B - Director by new ventures iii llc

2021-09-30 15:56:58 -0400 2021-09-29 J 314,886 d 1,759,654 indirect -2.9258 -2.0425 0.0 1 -2.9258 2

RIGGS RORY B - Director by new ventures i llc

2021-09-30 15:56:58 -0400 2021-09-29 S 22,173 $36.31 d 3,429,085 indirect -2.9258 -2.0425 0.0 1 -2.9258 2

RIGGS RORY B - Director

2021-09-30 15:56:58 -0400 2021-09-29 J 8,641 a 631,386 direct -2.9258 -2.0425 0.0 1 -2.9258 2

RIGGS RORY B - Director

2021-09-30 15:56:58 -0400 2021-09-29 S 24,648 $36.50 d 615,112 direct -2.9258 -2.0425 0.0 1 -2.9258 2

RIGGS RORY B - Director

2021-09-30 15:56:58 -0400 2021-09-28 S 40,000 $36.75 d 639,760 direct -2.9258 -2.0425 0.0 1 -2.9258 2

RIGGS RORY B - Director

2021-09-30 15:56:58 -0400 2021-09-10 G 7,692 d 534,059 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 22:15:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 21:45:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 21:15:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 20:45:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 20:15:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 19:45:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 19:15:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 18:45:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 18:15:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 17:45:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 17:15:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 16:45:04 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 16:15:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 15:45:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 15:15:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 14:45:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 14:15:05 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 13:45:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 13:15:03 UTC -0.18 0.25 8800000
ROYALTY PHARMA PLC- CL A RPRX 2021-10-26 12:45:03 UTC -0.18 0.25 8800000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Nuveen Investment Trust- Nuveen Equity Market Neutral Fund RPRX -4600.0 shares, $-184552.0 2021-05-31 N-PORT
RBB Fund, Inc.- Boston Partners Long/Short Research Fund RPRX -26229.0 shares, $-1052307.48 2021-05-31 N-PORT
Nuveen Investment Trust II- Nuveen Equity Long/Short Fund RPRX -10900.0 shares, $-437308.0 2021-05-31 N-PORT
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund RPRX -6783.0 shares, $-278035.17 2021-06-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund RPRX -10000.0 shares, $-409900.0 2021-06-30 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund RPRX -3407.0 shares, $-130147.4 2021-07-31 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund RPRX -362.0 shares, $-13828.4 2021-07-31 N-PORT

Elevate your investments